Angiotensin II Induces Abdominal Aortic Branch Aneurysms in Fibrillin-1C1041G/+ Mice

This study demonstrates that angiotensin II infusion, but not norepinephrine-induced hypertension, exacerbates aortic pathology and induces lethal dissections and branch aneurysms in Fbn1C1041G/+ mice, indicating that angiotensin II drives disease progression through mechanisms beyond simple blood pressure elevation.

The Gist

Imagine your body's main highway, the aorta, is a massive, flexible rubber hose that carries blood from your heart to the rest of your body. In people with Marfan syndrome, the "rubber" of this hose is made from a slightly defective material (a protein called Fibrillin-1). Because of this flaw, the hose is naturally weaker and prone to stretching or tearing, especially near the heart.

Scientists have created mice with this same "defective rubber" to study the disease. However, these mice usually only show mild stretching near the heart and rarely have the severe, life-threatening ruptures seen in humans. They were missing a key piece of the puzzle.

This study asked: What happens if we add extra stress to these weak hoses? Specifically, the researchers wanted to see if a chemical in our body called Angiotensin II (which tightens blood vessels and raises blood pressure) would turn a mild problem into a disaster.

Here is the story of what they found, using some simple analogies:

1. The "Stress Test"

The researchers took two groups of mice:

• The "Normal" Group: Mice with perfect rubber hoses.
• The "Marfan" Group: Mice with the defective Fibrillin-1 rubber.

They pumped a steady stream of Angiotensin II into these mice. Think of Angiotensin II as a "pressure cooker" setting. It doesn't just squeeze the hose; it chemically attacks the material, making it brittle and weak.

2. The Gender Gap (The "Male vs. Female" Story)

The results showed a dramatic difference between male and female mice, much like how some diseases affect men and women differently.

• The Male Mice: When the "pressure cooker" was turned on, the male mice with the defective rubber suffered a catastrophe. Within days, their aortas began to tear (dissect) or burst (rupture). Over 65% of them died, mostly because their main highway exploded either near the heart or in the belly. It was a total system failure.
• The Female Mice: The female mice with the same defective rubber were much tougher. While their aortas did stretch and get wider, they rarely died. They survived the stress test, but their "hoses" were still significantly damaged.

3. The "Branch Road" Discovery

The most exciting discovery was where the damage happened. Scientists expected the main highway (the aorta) to be the only problem. Instead, they found that the Angiotensin II caused new, dangerous bulges (aneurysms) at the "off-ramps."

Imagine a highway with exits leading to the liver and intestines (the celiac and superior mesenteric arteries). In the stressed male mice, these exit ramps didn't just stretch; they ballooned into dangerous, weak bubbles.

• The Analogy: It's like a weak rubber hose where the main pipe holds up, but the smaller tubes branching off it suddenly swell up and are about to pop. This is a huge deal because, in humans with Marfan syndrome, these exact "off-ramp" aneurysms are a major cause of complications, and this mouse model finally mimics that reality.

4. Was it Just the Pressure?

A big question was: Did the mice die just because their blood pressure went up, or was the Angiotensin II chemically attacking the vessel walls?

To test this, the researchers used a different chemical called Norepinephrine. This chemical is like a "pump" that raises blood pressure just as high as Angiotensin II does, but it doesn't have the same chemical "attack" properties.

• The Result: When they used the "pressure pump" (Norepinephrine), the mice's blood pressure went up, but nothing bad happened to their aortas. No deaths, no bursts, no branch aneurysms.
• The Lesson: This proves that high blood pressure alone isn't the villain. The Angiotensin II is like a "double agent"—it raises the pressure and chemically weakens the rubber, which is what causes the disaster.

The Bottom Line

This study is like finding the missing link in a detective story. It shows that for mice with Marfan-like defects, adding Angiotensin II turns a mild condition into a severe, life-threatening disease that looks exactly like the complex human version.

Key Takeaways for Everyone:

1. It's not just the main pipe: The danger isn't just in the big aorta; the smaller branches (off-ramps) are also vulnerable and can form dangerous bulges.
2. Chemical stress is worse than physical stress: High blood pressure alone didn't kill the mice; the specific chemical action of Angiotensin II was required to cause the damage.
3. New Hope for Research: Now that scientists have a mouse model that accurately mimics the severe, branch-aneurysm version of Marfan syndrome, they can use it to test new drugs and treatments to stop these "off-ramp" explosions before they happen.

Technical Summary

1. Problem Statement

• Background: Mutations in the FBN1 gene cause Marfan syndrome, characterized by diverse vascular pathologies including aortic aneurysms, dissections, and ruptures. While the Fbn1C1041G/+ mouse model is widely used to study aortopathy, it primarily mimics proximal thoracic aortic dilation and lacks the full spectrum of human disease, particularly regarding aortic branch aneurysms and spontaneous rupture.
• Knowledge Gap: The specific role of Angiotensin II (AngII) and elevated blood pressure in driving pathology beyond the proximal thoracic aorta in Fbn1C1041G/+ mice is incompletely defined. It is unclear if the observed pathologies are driven by AngII's specific signaling pathways or merely by the resulting hypertension.
• Objective: To determine if AngII infusion promotes pathology in the proximal thoracic aorta and, crucially, in the abdominal aorta and its branches in Fbn1C1041G/+ mice, and to distinguish between the effects of AngII versus blood pressure alone.

2. Methodology

• Animal Model: Littermate controls of Fbn1+/+ (wild-type) and Fbn1C1041G/+ (heterozygous variant) mice (both male and female) were used.
• Intervention Groups:
  • AngII Infusion: 1,000 ng/kg/min via subcutaneous osmotic pumps (28 days).
  • Norepinephrine (NE) Infusion: 5.6 mg/kg/day via osmotic pumps (28 days) to induce comparable hypertension without AngII receptor activation.
  • Controls: Vehicle (saline or ascorbic acid/saline).
• Duration: Mice were monitored for 28 days, with daily checks for mortality.
• Data Collection & Analysis:
  • Survival: Kaplan-Meier curves and log-rank tests.
  • Blood Pressure: Non-invasive tail-cuff systolic measurements.
  • Imaging:
    • In situ and ex vivo photography for gross morphology.
    • Micro-Computed Tomography (microCT): Used with vascular contrast agents (Microfil/Vascupaint) to visualize 3D vascular architecture and measure maximal diameters of the ascending aorta, suprarenal aorta, and specific branches (celiac, superior mesenteric, renal).
  • Histology: H&E, Verhoeff's iron hematoxylin (elastic fibers), Picrosirius red (collagen), and immunostaining for $\alpha$-smooth muscle actin and CD68 (macrophages).
• Statistical Analysis: Two-way ANOVA (parametric and non-parametric variants), Welch's t-test, and Bonferroni-corrected post-hoc tests.

3. Key Results

• Sexual Dimorphism in Mortality:
  • Males: AngII infusion caused a high mortality rate (~65%) in Fbn1C1041G/+ males, primarily due to aortic rupture (thoracic or abdominal). In contrast, Fbn1+/+ males had low mortality.
  • Females: Mortality was low (20%) in Fbn1C1041G/+ females and did not differ significantly from wild-types. All vascular deaths in females were due to thoracic rupture.
• Aortic Dilation:
  • AngII significantly increased ascending aortic diameters in both male and female Fbn1C1041G/+ mice.
  • Aortic length increased significantly in male Fbn1C1041G/+ mice but not in females.
• Novel Finding: Branch Aneurysms:
  • MicroCT revealed that AngII infusion induced aneurysms specifically at the celiac and superior mesenteric artery branches in Fbn1C1041G/+ mice (both sexes).
  • These branch aneurysms were not observed in Fbn1+/+ mice (even with AngII) nor in Fbn1C1041G/+ mice infused with saline.
  • Renal arteries showed only modest or no dilation.
• Histological Characterization:
  • Branch aneurysms exhibited elastic fiber fragmentation, collagen deposition, smooth muscle cell loss/disorganization, and significant macrophage (CD68+) infiltration.
  • The adjacent suprarenal aortic wall showed only modest thickening, indicating the pathology was spatially restricted to the branch points.
• Blood Pressure vs. AngII Specificity:
  • NE Infusion: Successfully elevated systolic blood pressure to levels comparable to AngII infusion in both genotypes.
  • Outcome: NE infusion did not cause increased mortality, aortic dilation, or branch aneurysms in Fbn1C1041G/+ mice.
  • Conclusion: The pathology is driven by AngII-specific mechanisms (e.g., AT1 receptor signaling, inflammation) rather than hemodynamic stress (blood pressure) alone.

4. Key Contributions

• Model Expansion: This study expands the utility of the Fbn1C1041G/+ mouse model by demonstrating that AngII infusion recapitulates the full spectrum of Marfan-like vascular disease, including abdominal aortic rupture and branch aneurysms, which were previously absent in this model.
• Mechanistic Insight: By using Norepinephrine as a control, the authors definitively proved that the development of branch aneurysms is AngII-dependent and not merely a consequence of hypertension.
• Clinical Relevance: The identification of celiac and superior mesenteric branch aneurysms in this model mirrors recent clinical observations in Marfan syndrome patients, suggesting these vessels are high-risk sites for intervention.
• Sexual Dimorphism: The study highlights distinct mechanisms for aneurysm formation (present in both sexes) versus rupture/mortality (predominantly in males) under AngII stress.

5. Significance

• Therapeutic Implications: The findings suggest that therapies targeting AngII signaling (e.g., ARBs) may be critical for preventing branch aneurysms in Marfan patients, independent of blood pressure control.
• Diagnostic Focus: Clinicians should be vigilant for aneurysms in the celiac and superior mesenteric arteries in Marfan syndrome patients, as these are now recognized as common and potentially dangerous sites of pathology.
• Research Platform: The established model provides a robust platform for investigating the molecular mechanisms of branch-specific aneurysm formation and testing potential pharmacological interventions.